Advertisement

Topics

Bioclone Australia Pty Limited Company Profile

17:09 EST 23rd November 2017 | BioPortfolio

Bioclone is an Australian-based subsidiary of Hitachi Chemical Co., Ltd., specialising in the manufacture of high quality immunodiagnostic products for the medical and research laboratory markets.Bioclone was formed in 1981 to take advantage of Australian expertise in medical research and biotechnology. A collaborative project between the CSIRO and the Garvan Institute for Medical Research gave Bioclone an excellent range of monoclonal antibodies to pituitary hormones from which diagnostic kits were later developed.Bioclone now produces Australia's largest range of immunoassay products for the medical diagnostics market. The products are marketed worldwide through a network of distributors.Bioclone has continued to invest in innovation and new product development both through collaboration with research organisations and through its own Research and Development team.

Location

71-73 Railway Parade
Marrickville
New South Wales
NSW 2204
Australia

Contact

Phone: 61 (0)2 9517 1966
Fax: 61 (0)2 9517 2990
Email: sales1@bioclone.com.au


News Articles [314 Associated News Articles listed on BioPortfolio]

Luggage screening intensified after Australia airplane plot

CANBERRA, Australia (AP) — Security remained heightened in airports around Australia with more intense screening of luggage after law enforcement officials thwarted what a police chief described on ...

UN accuses Australia of breaching refugee deal

The UN accused Australia Monday of backtracking on a deal to relax its strong stance on asylum-seekers and resettle some refugees now held in overseas detention on home soil. The UN High Commissioner...

Australia’s TGA progresses Provisional Approval pathway for medicines

Australia’s Therapeutic Good Administration (TGA) has released draft guidance documentation for the…

Reforms will tighten regulation of CAR T-cell therapies in Australia

Australia’s medicines regulator, the Therapeutic Goods Administration, has announced it will reform…

Australia to simplify procedure for pharma marketing complaints

Australia is to create a simpler system for members of the public to complain about the advertising of…

Roche secures regulatory approval for Ocrevus in Australia

Australia’s medicines regulator, the Therapeutic Goods Administration, has approved Swiss pharma firm…

Australia cautiously enters medical marijuana market

At a secret location in Australia's southeast, Peter Crook delicately tends to a two-month-old cannabis cutting.

Telix Pharmaceuticals Limited Launches $50 Million Underwritten Initial Public Offering (ASX: TLX)

MELBOURNE, Australia, Oct. 23, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (Telix, the Company), an Australian biopharmaceutical company focused on the development of diagnostic and ...

PubMed Articles [451 Associated PubMed Articles listed on BioPortfolio]

Dietitians Association of Australia 34th National Conference, "Cultivating Fresh Evidence", Hobart, Tasmania, Australia, 18-20 May 2017.

A national study of the molecular epidemiology of HIV-1 in Australia 2005-2012.

Rates of new HIV-1 diagnoses are increasing in Australia, with evidence of an increasing proportion of non-B HIV-1 subtypes reflecting a growing impact of migration and travel. The present study aims ...

HPV vaccine coverage is increasing in Australia.

Laparoscopic pancreaticoduodenectomy in Brisbane, Australia: an initial experience.

The role of minimally invasive approach for pancreaticoduodenectomy has not yet been well defined in Australia. We present our early experience with laparoscopic pancreaticoduodenectomy (LPD) from Bri...

Identifying factors that lead to the persistence of imported gonorrhoeae strains: a modelling study.

The importation of Neisseria gonorrhoeae (NG) strains from overseas is believed to be the main source of antimicrobial resistance in Australia. With recent sporadic cases of ceftriaxone-resistant gono...

Clinical Trials [122 Associated Clinical Trials listed on BioPortfolio]

Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial

Despite all prevention efforts, many people in Australia continue to be infected with HIV. The Seventh National HIV Strategy 2014-2017 in Australia aims to work towards the elimination of ...

Patient Retention in HIV Medical Care in a Primary Care Practice in Australia

The purpose of this study is to determine linkage and retention in care in patients with HIV infection and reasons for loss to follow up Care in a High HIV-caseload Inner City Primary Care...

Control and Eradication Within Australia of Hepatitis C From People Living With HIV

The purpose of this study is to evaluate the feasibility of rapid scale-up of new hepatitis C (HCV) treatments, known as interferon-free Direct Acting Antiviral (DAA) drugs, and impact on ...

Turning Night Into Day: Transcontinental Provision of Telehealth By and For the Emory Community

The purpose of the study is to determine if temporarily relocating clinicians who deliver remote care using the eICU telehealth system to Sydney, Australia will lead to greater job satisfa...

KONTAKT Australia a Social Skills Group Training for Adolescents on the Autism Spectrum

This study evaluates the KONTAKT social skills group training in Australian adolescents on the autism spectrum compared to an active control group which is a group cooking class

Companies [503 Associated Companies listed on BioPortfolio]

Bioclone Australia Pty Limited

Bioclone is an Australian-based subsidiary of Hitachi Chemical Co., Ltd., specialising in the manufacture of high quality immunodiagnostic products for the medical and research laboratory markets.Bioc...

Starpharma Holdings Ltd

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY), located in Melbourne Australia, is an ASX 300 company and is a world leader in the development of dendrimer products for pharma...

Circadian Technologies Limited

Circadian Technologies Limited is an emerging leader in the field of angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs),...

Food Science Australia

Food Science Australia is Australia's largest and most diversified food research organisation and a joint venture of CSIRO and the Victorian Government. We are committed to turning scientific researc...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

More Information about "Bioclone Australia Pty Limited" on BioPortfolio

We have published hundreds of Bioclone Australia Pty Limited news stories on BioPortfolio along with dozens of Bioclone Australia Pty Limited Clinical Trials and PubMed Articles about Bioclone Australia Pty Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bioclone Australia Pty Limited Companies in our database. You can also find out about relevant Bioclone Australia Pty Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...


Corporate Database Quicklinks



Searches Linking to this Company Record